Carmen S. Fiorella
Pagani, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Upadacitinib is efficacious in reducing the alexithymic trait in adult patients with moderate-to-severe atopic dermatitis: a prospective multicenter real-life study.
Journal: Italian journal of dermatology and venereology
Published: October 03, 2025
Brodalumab Efficacy in Psoriasis Patients with Inadequate Response to IL-23 or IL-12/23 Inhibitors: Multicenter Italian Retrospective Analysis - IL PSO (Italian Landscape Psoriasis).
Journal: Dermatology practical & conceptual
Published: March 06, 2025
Effectiveness, speed of action and safety of brodalumab in elderly psoriasis patients: a multicenter real-world study - IL PSO (Italian Landscape Psoriasis).
Journal: The Journal of dermatological treatment
Published: February 06, 2025
BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis).
Journal: Clinical and experimental dermatology
Published: January 17, 2025
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis).
Journal: Journal of clinical medicine
Published: December 31, 2024
The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis).
Journal: Clinical and experimental dermatology
Published: September 15, 2024
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 22, 2024
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis).
Journal: The Journal of dermatological treatment
Published: August 20, 2024
Early intervention and cumulative life course impairment in psoriasis: a review.
Journal: Clinical and experimental dermatology
Published: May 05, 2024
Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis.
Journal: Dermatology practical & conceptual
Published: April 21, 2023
Efficacy, safety and patient's satisfaction for treatment of genital psoriasis with tildrakizumab: a case series and review of literature.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 27, 2022
Treatment with secukinumab for plaque psoriasis in patients with infectious comorbidities and latent tuberculosis: A multi-case report analysis.
Journal: Clinical case reports
Published: November 18, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026